Elevated pressure in the portal venous system redirects blood through collateral vessels, including veins in the esophagus and stomach. These vessels enlarge as they carry redirected flow and become fragile, creating a risk of rupture. Once bleeding begins, the resulting blood loss can cause hematemesis, melena, and hemodynamic instability, making rapid recognition essential.
A ruptured varix can produce acute hemorrhage, allowing substantial blood loss over a short period. Hematemesis or melena may signal the bleeding, while hemodynamic instability indicates that circulation is being affected. This combination explains why treatment must address both immediate resuscitation and the bleeding source rather than relying on observation alone.
Varices arise from collateral vessels created by increased portal venous pressure, so management must address both hemorrhage and the pressure driving the abnormal circulation. The overview identifies vasoactive medication, prophylactic antibiotics, and urgent endoscopic treatment as coordinated measures. This differs from an approach focused only on local control of bleeding.
Acute care combines resuscitation with vasoactive medication, prophylactic antibiotics, and urgent endoscopic treatment. Resuscitation supports circulation during blood loss, while vasoactive therapy is used as part of the immediate medical response and antibiotics are given preventively. Together with endoscopic control, these measures support prompt treatment of a life-threatening episode.
Management begins with rapid resuscitation while clinicians initiate vasoactive medication and prophylactic antibiotics. Urgent endoscopy then provides direct treatment, commonly through variceal band ligation. This sequence addresses immediate instability and the bleeding site without delaying definitive control. The goal is to reduce the consequences of acute hemorrhage and prevent further deterioration.
Variceal band ligation is an urgent endoscopic treatment used to control bleeding from the abnormal veins. Endoscopy provides access to the bleeding area, allowing the varix to be treated directly rather than managed only with systemic measures. It is identified as a common intervention when acute variceal hemorrhage requires definitive local control.
A transjugular intrahepatic portosystemic shunt may be considered when bleeding persists or recurs despite initial management. By reducing portal pressure, this intervention targets the underlying pressure problem contributing to variceal formation and rupture. Its role is therefore escalation therapy for difficult cases, rather than the first step in every bleeding episode.
Variceal bleeding is a life-threatening complication associated with advanced liver disease and can progress to shock, rebleeding, or death. Prompt recognition allows clinicians to begin resuscitation, medical therapy, antibiotics, and urgent endoscopic treatment without delay. If bleeding continues or returns, shunt placement may reduce portal pressure and provide additional control.